Longitudinal trends in community-onset bacteraemia caused by ceftriaxone non-susceptible

Raveena Patel, Laura G Stoudenmire, Cong Cheng, Xianyan Chen, Bryan P White, Daniel B Chastain

Abstract read

In one paragraph

Article in JAC-antimicrobial resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Raveena PatelDepartment of Pharmacy, Phoebe Putney Memorial Hospital, Albany, GA 31701, USA.

Laura G StoudenmireDepartment of Pharmacy, Phoebe Putney Memorial Hospital, Albany, GA 31701, USA.

Cong ChengDepartment of Statistics, University of Georgia, Franklin College of Arts and Sciences, Athens, GA 30602, USA.

Xianyan ChenDepartment of Epidemiology & Biostatistics, University of Georgia College of Public Health, Athens, GA 30602, USA.ORCID https://orcid.org/0000-0002-1806-0883

Bryan P WhiteDepartment of Pharmacy, OU Health Medical Center, Oklahoma City, OK 73104, USA.ORCID https://orcid.org/0000-0001-5657-7069

Daniel B ChastainDepartment of Clinical and Administrative Pharmacy, University of Georgia College of Pharmacy, Albany, GA 31701, USA.ORCID https://orcid.org/0000-0002-4018-0195

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The increasing prevalence of ESBL-producing Enterobacterales complicates treatment and worsens outcomes. However, contemporary data describing the prevalence and temporal trends in established risk factors for community-onset ceftriaxone non-susceptible (CRO-NS) bacteraemia remain limited. Methods: This retrospective cohort study included adults with community-onset bacteraemia due to Results: Among 1392 patients with community-onset bacteraemia, 127 (9.1%) were due to CRO-NS isolates, with Conclusion: Community-onset CRO-NS bacteraemia more than doubled over nine years, driven primarily by

Identifiers

PMID41696712

DOI10.1093/jacamr/dlag014

PMCPMC12900576

What Socratic holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.